You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 6月17日港股收盤

根據uSMART輿情監測數據,17日港股交易時段,市場關注指數最高的5只股票是京東集團-SW、贛鋒鋰業、協鑫科技、華潤醫藥、微盟集團。

6月17日—港股關注排行TOP5

輿情變化榜單

京東集團-SW

個股K線圖

關注度第一爲京東集團-SW,該股今日收盤上漲6.09%,報於261.20港元。近5個交易日累計上漲4.15%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆生指數午間收漲0.78%報21009點 京東集團漲4.31%領漲藍籌

恆科指午盤初拉昇2.7% 京東集團-SW升6%領跑 聖彼得堡證券交易所擬下週起交易12只恆指藍籌

贛鋒鋰業

個股K線圖

關注度第二爲贛鋒鋰業,該股今日收盤上漲5.86%,報於81.25港元。近5個交易日累計下跌27.20%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

天齊鋰業將來港上市 影子股贛鋒鋰業1772有得炒?

部分特斯拉概念股上揚 贛鋒鋰業漲7.1%

協鑫科技

個股K線圖

關注度第三爲協鑫科技,該股今日收盤上漲5.06%,報於3.32港元。近5個交易日累計下跌0.30%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

新能源車、協鑫及贛鋒隨A股同業升逾2%-8% 理想汽車最強

協鑫科技漲3.46% 徐州基地新增3萬噸顆粒硅產能投產

華潤醫藥

個股K線圖

關注度第四爲華潤醫藥,該股今日收盤上漲8.97%,報於4.86港元。近5個交易日累計上漲10.20%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

港股有3只股票創新高,華潤醫藥大漲8.97%

華潤醫藥一度升15%、刷新一年來高點 機構指Q2起醫藥零售料持續迎來逐季恢復

微盟集團

個股K線圖

關注度第五爲微盟集團,該股今日收盤上漲2.91%,報於5.31港元。近5個交易日累計下跌3.28%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

微盟616購物節助力疫情後零售商家加速恢復,數字零售進入2.0階段

616數造零售直播大會 微盟聯合CCFA發佈連鎖品牌數字化報告

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

6月17日—港股輿情轉折預警

輿情變化榜單

京東集團-SW

個股K線圖

京東集團-SW輿情扭轉指數達100,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

恆生指數午間收漲0.78%報21009點 京東集團漲4.31%領漲藍籌

恆科指午盤初拉昇2.7% 京東集團-SW升6%領跑 聖彼得堡證券交易所擬下週起交易12只恆指藍籌

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account